Loading clinical trials...
Loading clinical trials...
We aim to compare the response to ketamine/dexmedetomidine and ketamine/propofol combinations used in hepatic patients with child-Pugh classification (class A), and early (class B) undergoing UGIE.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tamer Nabil Abdelrahman
NCT03839784 · Cognitive Decline, Cognitive Change, and more
NCT07103616 · Anesthesia; Reaction, Anesthesia
NCT05869578 · Perioperative Complication, Perioperative/Postoperative Complications, and more
NCT05610007 · Anesthesia, Anesthesia; Reaction
NCT03276533 · Anesthesia; Reaction
Faculty of medicine, Ain-Shams university
Cairo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions